Journal article

Mutational inhibition of c-Myb or p300 ameliorates treatment-induced thrombocytopenia

Douglas J Hilton, Benjamin T Kile, Warren S Alexander

Blood | AMER SOC HEMATOLOGY | Published : 2009

Grants

Awarded by Australian National Health and Medical Research Council (Canberra, Australia)


Awarded by Independent Research Institutes Infrastructure Support Scheme


Awarded by National Heart, Lung, and Blood Institute (Bethesda, MD)


Awarded by NATIONAL HEART, LUNG, AND BLOOD INSTITUTE


Funding Acknowledgements

The authors thank Kelly Trueman, Jason Corbin, Janelle Lochland, Craig Hyland, and Katya Henley for expert technical assistance. This work was supported by the Australian National Health and Medical Research Council (Canberra, Australia; Program Grant 461219, Project Grant 461247, Fellowships, D. J. H., W. S. A.; and Independent Research Institutes Infrastructure Support Scheme Grant 361646), an Australian Research Council (Canberra, Australia) Fellowship (B. T. K.), the National Heart, Lung, and Blood Institute (Bethesda, MD; RO1 grant HL080019), MuriGen Pty, Ltd (Melbourne, Australia; collaborative research grant), the Australian Cancer Research Fund, and a Victorian State Government (Melbourne, Australia) Operational Infrastructure Support grant.